2 years ago

Pencil Biosciences Raises £5.6 Million Seed Round for Gene Modulation Technology

  • Pencil Biosciences, a gene modulation technology startup based in Cheshire, has raised £5.6 million in seed funding

  • The round was led by Northern Gritstone and saw participation from Octopus Ventures, Martlet Capital, and others

  • The funding will support the development of Pencil Biosciences' gene editing technology, which has applications in healthcare and agriculture.

      • ProblemHealthcare

      "Developing new therapeutic options for patients with rare diseases and cancer is a major challenge in the healthcare industry. Current treatments are often ineffective, expensive, and have significant side effects."

      Solution

      "Pencil Biosciences is developing a gene modulation technology that can be used to engineer cell lines, create novel diagnostics, and improve agricultural practices. This technology has the potential to revolutionize the treatment of rare diseases and cancer by providing more effective, affordable, and safer therapies."

      Covered on